Literature DB >> 2095300

Hyperaminoacidemia in epileptic children treated with valproic acid.

M Castro-Gago1, E Rodrigo-Saez, I Novo-Rodriguez, M F Camiña, S Rodriguez-Segade.   

Abstract

Serum amino acids were determined in 22 epileptic children treated with valproic acid. This treatment caused hypocarnitinemia in all, and hyperammonemia in 16. Regardless of the blood ammonia levels, values for glutamic acid, arginine, glycine, serine and alanine were higher than those of normal controls, while aspartic acid and ornithine were lower. These findings suggest that valproate causes intramitochondrial dysfunction of the urea cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095300     DOI: 10.1007/bf00302087

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  22 in total

1.  Serum carnitine during valproic acid therapy.

Authors:  M C Laub; I Paetzke-Brunner; G Jaeger
Journal:  Epilepsia       Date:  1986 Sep-Oct       Impact factor: 5.864

2.  Reye-like syndrome associated with valproic acid therapy.

Authors:  N Gerber; R G Dickinson; R C Harland; R K Lynn; L D Houghton; J I Antonias; J C Schimschock
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

3.  Hyperammonemia with valproic acid therapy.

Authors:  D L Coulter; R J Allen
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

4.  A mechanism for valproate-induced hyperammonemia.

Authors:  F X Coude; D Rabier; L Cathelineau; G Grimber; P Parvy; P P Kamoun
Journal:  Pediatr Res       Date:  1981-06       Impact factor: 3.756

5.  Fatal Reye-like syndrome associated with valproic acid.

Authors:  R S Young; I Bergman; D L Gang; E P Richardson
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

6.  Sodium valproate and hyperglycinaemia.

Authors:  K Bartlett
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

7.  Valproic acid-induced hyperammonemia in mentally retarded adults.

Authors:  C A Williams; S Tiefenbach; J W McReynolds
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

8.  Valproate-induced hepatic injury: analyses of 23 fatal cases.

Authors:  H J Zimmerman; K G Ishak
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

9.  Dipropylacetate (valproate) and glycine metabolism.

Authors:  J Jaeken; L Corbeel; P Casaer; H Carchon; E Eggermont; R Eeckels
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

10.  Influence of valproic acid on hepatic carbohydrate and lipid metabolism.

Authors:  C M Becker; R A Harris
Journal:  Arch Biochem Biophys       Date:  1983-06       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.